Chronic hepatitis C virus infection after treatment for pediatric malignancy

Blood

Volumn 90, Issue 3, 1997, Pages 1315-1320

  Cesaro, Simone ^a   Petris, Maria Grazia ^b   Rossetti, Flavio ^b   Cusinato, Riccardo ^b   Pipan, Corrado ^b   Guido, Maria ^b   Masiero, Lucia ^b   Botta, Giuseppe A ^b   Meloni, Giovanni A ^b   Zanesco, Luigi ^b  

^a Clin Ped   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADOLESCENT; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BLOOD TRANSFUSION; CHILD; CHILDHOOD CANCER; CHRONIC LIVER DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; INFANT; LIVER BIOPSY; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 0030786630     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.3.1315.1315_1315_1320     Document Type: Article

References (31)

1. Armitage JO, Burns CP, Kent TH: Liver disease complicating the management of acute leukemia during remission. Cancer 41:737, 1978
2. Locasciulli A, Alberti A, Rossetti F, Santamaria M, Santoro N, Madon E, Miniero R, Lo Curto M, Tamaro P, Casale F, Nespoli L, Tucci F, Masera G: Acute and chronic hepatitis in childhood leukemia: A multicentric study from the Italian Pediatric Cooperative Group for Therapy of Acute Leukemia (AIL-AIEOP). Med Pediatr Oncol 13:203, 1985
3. Hetherington ML, Buchanam GR: Elevated serum transaminase values during therapy for acute lymphoblastic leukemia correlated with prior blood transfusions. Cancer 62:1614, 1988
4. Barrera JM, Bruguera M, Ercilla G, Sanchez-Tapias JM, Gil MP, Gil C, Costa J, Gelabert A, Rodes J, Castillo R: Incidence of non-A non-B hepatitis after screening blood donors for antibodies to hepatitis C virus and surrogate markers. Ann Intern Med 115:596, 1991
5. Colombo M, Oldani S, Donato MF, Borzio M, Santese R, Roffi L, Vigano P, Cargnel A: A multicenter prospective study of posttransfusion hepatitis in Milan. Hepatology 7:709, 1987
6. Rossetti F, Messina C, Pillon M, Zanesco L: Liver disease and childhood leukemia. Riv Ital Pediatr (IJP) 17:16, 1991
7. Iwarson S, Jilg W, Stroffolini T: Substantial decline of notified hepatitis B in major part of Europe after 1985. Scand J Infect Dis 26:19, 1994
8. Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M: Isolation of a c-DNA clone derived from a blood borne non-A, non-B viral hepatitis genoma. Science 244:356, 1989
9. Kuo G, Choo QL, Alter HG, Gitnick GL, Redeker AG, Purcell RH, Miyamura T, Dienstag JL, Alter MJ, Stevens CE: An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis. Science 244:362, 1989
10. Koretz RL, Abbey H, Coleman E, Gitnick G: Non-A, non-B posttransfusion hepatitis: Looking back in the second decade. Ann Intern Med 119:110, 1993
11. Tong MJ, El-Farra NS, Reikes AR, Co RL: Clinical outcomes after transfusion-associated hepatitis C. N Engl J Med 332:1463, 1995
12. Tsukuma H, Hiyama T, Tanaka S, Nakao M, Yabuuchi T, Kitamura T, Nakanishi K, Fujmoto I, Inoue A, Yamazaki H, Kawashima T: Risk factors for hepatocellular carcinoma among patients with chronic liver disease. N Engl J Med 328:1797, 1993
13. Seef LB, Buskell-Bales Z, Wright EC, Durako SJ, Alter HJ, Iber FL, Hollinger B, Gitnick G, Knodell RG, Perrillo RP, Stevens CE, Hollingsworth CH, and the National Heart, Lung, and Blood Institute Study Group: Long term mortality after transfusion-associated non-A, non-B hepatitis. N Engl J Med 327:1906, 1992
14. Chomczynski P, Sacchi N: Single-step method of RNA isolation by guanidium thiocyanate phenol-chloroform extraction. Anal Biochem 162:156, 1987
15. Hokamoto H, Okada S, Sugiyama Y, Tanaka T, Sugai Y, Akahane Y, Machida A, Mishiro S, Yoshizawa H, Miyakawa Y, Mayumi M: Detection of hepatitis C virus RNA by a two-stage polymerase chain reaction with two pairs of primers deduced from 5′-noncoding region. Jpn J Exp Med 60:215, 1990
16. Cha TA, Kolberg J, Irvine B, Stempien M, Beall E, Yano M, Choo QL, Houghton M, Kuo G, Han JH, Urdea MS: Use of a signature sequence of hepatitis C virus for detection of viral RNA in human serum and plasma. J Clin Microbiol 29:2528, 1991
17. Cha TA, Beall E, Irvine B, Stempien M, Yano M, Choo QL, Houghton M, Kuo G, Han JH, Urdea MS: At least five related but distinct, hepatitis C viral genomes exist. Proc Natl Acad Sci USA 89:7144, 1992
18. Simmonds P, Holmes EC, Cha TA: Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74:2391, 1993
19. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ: Classification of chronic viral hepatitis: Diagnosis, grading and staging. Hepatology 19:1513, 1994
20. Romanò L, Azara A, Chiaramonte M, De Mattia D, Giammanco A, Moschen ME, Scarpa B, Stroffolini T, Zanetti AR: Low prevalence of anti-HCV antibody among Italian children. Infection 22:350, 1994
21. Locasciulli A, Cavalletto D, Pontisso P, Cavalletto L, Scovena E, Uderzo C, Masera G, Alberti A: Hepatitis virus C serum markers and liver disease in children with leukemia during and after chemotherapy. Blood 82:2564, 1993
22. Aricò M, Maggiore G, Silini E, Bono F, Viganò C, Cerino A, Mondelli MU: Hepatitis C virus infection in children treated for acute lymphoblastic leukemia. Blood 84:2919, 1994
23. Fink EM, Hocker-Schultz S, Mohr W, Puchhammer-Stockl E, Hoffmann H, Zoubek A, Pawlowsky J, Hocker P, Gadner H: Association of hepatitis C infection with chronic liver disease in pediatric cancer patients. Eur J Pediatr 152:490, 1993
24. Watanabe J, Minegishi K, Mitsumori T, Ishfuji M, Oguchi T, Ueda M, Tokunaga E, Tanaka E, Kiyosawa K, Furuta S, Katayama T, Kuo G, Choo QL, Houghton M, Nishioka K: Prevalence of anti-HCV antibody in blood donors in the Tokyo area. Vox Sang 59:86, 1990
25. Esteban JI, Gonzàlez A, Hernàndez JM, Villadomiu L. Sanchez C, Lopez-Talavera JC, Lucea D, Martin-Vega C, Vidal X, Esteban R, Guardia J: Evaluation of antibodies to hepatitis C virus in a study of transfusion-associated hepatitis. N Engl J Med 323:1107, 1990
26. Donahue JG, Munoz A, Ness PM, Brown DE, Yawn DH, McAllister HA, Reitz BA, Nelson KE: The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327:369, 1992
27. Alter MJ, Margolis HS, Krawczinski K, Judson FN, Mares A, Alexander J, Pin YU, Miller JK, Gerber MA, Sampliner RE, Meeks EL, Beach MJ: The natural history of community-acquired hepatitis C in the United States. N Engl J Med 327:1899, 1992
28. Dusheiko G, Simmonds P: Sequence variability of hepatitis C and its clinical relevance. J Viral Hepatitis 1:3, 1994
29. Fattovich G, Tagger T, Brollo L, Giustina G, Pontisso P, Realdi G, Alberti A, Ruol A: Hepatitis C virus infection in chronic hepatitis B virus carriers. J Infect Dis 163:400, 1991
30. Sheen IS, Liaw YF, Lin DY, Chu CM: Role of hepatitis C and delta viruses in the termination of chronic hepatitis B surface antigen carrier state: A multivariate analysis in a longitudinal follow-up study. J Infect Dis 170:358, 1994
31. Rossetti F, Zancan L, Perilongo G, Zanesco L: Hepatocellular carcinoma following chronic delta virus hepatitis in a patient cured of leukemia. Med Pediatr Oncol 19:137, 1991